735 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
AMGN Amgen Inc. $200.81 $129.98B N/A
Article Searches
Novartis Tests New Alzheimer's Drugs on People Who Don't Have the Disease https://www.wsj.com/articles/novartis-tests-new-alzheimers-drug-on-people-who-dont-have-the-disease-1492871315?mod=pls_whats_news_us_business_f Apr 23, 2017 - Subjects at high risk of developing Alzheimer’s—but who don’t actually have the disease—are being recruited to help test two experimental treatments from Novartis AG, in a new focus on preventive treatment.
The 9 Best-Selling Prescription Drugs in 2016 (Each One Topped $6 Billion) https://www.fool.com/investing/2017/06/30/the-9-best-selling-prescription-drugs-in-2016-each.aspx?source=iedfolrf0000001 Jun 30, 2017 - These prescription drugs raked in billions of dollars last year. But several of them might not be so lucrative for much longer.
3 Dividend Stocks You May Be Overlooking https://www.fool.com/investing/2017/07/09/3-dividend-stocks-you-may-be-overlooking.aspx?source=iedfolrf0000001 Jul 09, 2017 - Why Cisco Systems, Taiwan Semiconductor Manufacturing Co., and Amgen are dividend stocks you shouldn't ignore.
The 'Fearless Girl' Statue Isn't a Symbol, It Is an Advertisement http://www.zacks.com/stock/news/254260/the-fearless-girl-statue-isnt-a-symbol-it-is-an-advertisement?cid=CS-ZC-FT-254260 Mar 28, 2017 - The Fearless Girl statue has taken New York City by storm. However, this statue, which is facing down the Charging Bull, is actually an ad.
Read This Before You Buy Biotech Stocks https://www.fool.com/investing/2017/04/23/read-this-before-you-buy-biotech-stocks.aspx?source=iedfolrf0000001 Apr 23, 2017 - Looking to buy biotech stocks? Here are 7 important things to know.
These 3 Biotech Stocks Have Ballooned in 2017, but Will They Pop? https://www.fool.com/investing/2017/05/22/these-3-biotech-stocks-have-ballooned-in-2017-but.aspx?source=iedfolrf0000001 May 22, 2017 - It's been a pretty good year for biotech, but these three stocks are outperforming their industry peers. Can they keep it up?
9 Brand-Name Companies That Provide at Least a 5% 401(k) Match https://www.fool.com/investing/2017/05/03/9-brand-name-companies-that-provide-at-least-a-5-4.aspx?source=iedfolrf0000001 May 03, 2017 - These companies are near the head of the class when it comes to this lucrative employee benefit.
Better Buy: Amgen Inc. vs. Biogen https://www.fool.com/investing/2017/04/26/better-buy-amgen-inc-vs-biogen.aspx?source=iedfolrf0000001 Apr 26, 2017 - Which biotech is the better stock?
Bleak Outlook for Big Drug Makers https://www.wsj.com/articles/bleak-outlook-for-big-drug-makers-1493051153?mod=rss_markets_main Apr 25, 2017 - Without price increases or deals to boost earnings, the pharmaceuticals sector faces a weak earnings season.
5 Things AbbVie Management Just Said That You'll Want to Know https://www.fool.com/investing/2017/05/03/5-things-abbvie-management-just-said-that-youll-wa.aspx?source=iedfolrf0000001 May 03, 2017 - Top AbbVie executives talk about protecting Humira, tax reform, and other key topics at the Deutsche Bank healthcare conference.

Pages: 123456...74

Page 1>